Hostname: page-component-745bb68f8f-hvd4g Total loading time: 0 Render date: 2025-01-23T17:28:10.344Z Has data issue: false hasContentIssue false
Accepted manuscript

A roadmap for understanding sulfadoxine-pyrimethamine in malaria chemoprevention

Published online by Cambridge University Press:  23 January 2025

Thiery Masserey
Affiliation:
Swiss Tropical and Public Health Institute, University of Belgrade, Allschwil, Switzerland University of Basel, Basel, Switzerland
Lydia Braunack-Mayer
Affiliation:
Swiss Tropical and Public Health Institute, University of Belgrade, Allschwil, Switzerland University of Basel, Basel, Switzerland
R Scott Miller
Affiliation:
Gates Medical Research Institute, Cambridge MA, USA
Jörg J Möhrle
Affiliation:
Swiss Tropical and Public Health Institute, University of Belgrade, Allschwil, Switzerland University of Basel, Basel, Switzerland Medicines for Malaria Venture, Geneva, Switzerland
Melissa A Penny*
Affiliation:
Swiss Tropical and Public Health Institute, University of Belgrade, Allschwil, Switzerland University of Basel, Basel, Switzerland The Kids Institute, Nedlands, Western Australia, Australia Centre for Child Health Research, University of Western Australia, Perth, Western Australia, Western Australia
*
Corresponding author: Melissa A Penny, Email: melissa.penny@uwa.edu.au
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Review Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2025. Published by Cambridge University Press.

Footnotes

§

These authors contributed equally